<?xml version="1.0"?>
<!DOCTYPE html>
<html lang="no">
  <head>
    <title>Forskrift om endring i forskrift om legemidler (legemiddelforskriften)</title>
    <base href="https://lovdata.no/"/>
  </head>
  <body>
    <header class="documentHeader" id="hode">
      <dl class="data-document-key-info">
        <dt class="legacyID">Datokode</dt>
        <dd class="legacyID">FOR-2021-12-12-3513</dd>
        <dt class="dokid">DokumentID</dt>
        <dd class="dokid">LTI/forskrift/2021-12-12-3513</dd>
        <dt class="ministry">Departement</dt>
        <dd class="ministry">
          <ul>
            <li>Helse- og omsorgsdepartementet</li>
          </ul>
        </dd>
        <dt class="subunit">Etat</dt>
        <dd class="subunit">
          <ul>
            <li>Spesialisthelsetjenesteavdelingen</li>
          </ul>
        </dd>
        <dt class="dateInForce">I kraft fra</dt>
        <dd class="dateInForce">2022-01-01</dd>
        <dt class="changesToDocuments">Endrer</dt>
        <dd class="changesToDocuments">
          <ul>
            <li>forskrift/2009-12-18-1839</li>
          </ul>
        </dd>
        <dt class="basedOn">Hjemmel</dt>
        <dd class="basedOn">
          <ul>
            <li>lov/1992-12-04-132/&#xA7;6</li>
            <li>lov/1992-12-04-132/&#xA7;10</li>
            <li>lov/1992-12-04-132/&#xA7;16</li>
            <li>lov/1992-12-04-132/&#xA7;18</li>
          </ul>
        </dd>
        <dt class="dateOfPublication">Kunngjort</dt>
        <dd class="dateOfPublication">2021-12-14 15:30</dd>
        <dt class="journalNumber">Journalnummer</dt>
        <dd class="journalNumber">2021-2050</dd>
        <dt class="titleShort">Korttittel</dt>
        <dd class="titleShort">Endr. i legemiddelforskriften</dd>
        <dt class="title">Tittel</dt>
        <dd class="title">Forskrift om endring i forskrift om legemidler (legemiddelforskriften)</dd>
        <dt class="miscInformation">Annet om dokumentet</dt>
        <dd class="miscInformation"><strong>Hjemmel:</strong> Fastsatt av Helse- og omsorgsdepartementet 12. desember 2021 med hjemmel i lov 4. desember 1992 nr. 132 om legemidler m.v. (legemiddelloven) &#xA7; 6, &#xA7; 10, &#xA7; 16 og &#xA7; 18.</dd>
        <dt class="refid">RefID</dt>
        <dd class="refid">forskrift/2021-12-12-3513</dd>
        <dt class="table-of-contents">Innhold</dt>
        <dd class="table-of-contents">
          <ul class="tocTopUl">
            <li>Forskrift om endring i forskrift om legemidler (legemiddelforskriften)<ul class="tocSubUl"><li>I</li><li>II</li></ul></li>
          </ul>
        </dd>
      </dl>
    </header>
    <main class="documentBody" data-lovdata-URL="LTI/forskrift/2021-12-12-3513" id="dokument">
      <h1>Forskrift om endring i forskrift om legemidler (legemiddelforskriften)</h1>
      <section class="section" data-name="kapI" id="kapittel-1" data-lovdata-URL="LTI/forskrift/2021-12-12-3513/KAPITTEL_1">
        <h2 data-text-align="center">I</h2>
        <article class="legalP" id="kapittel-1-ledd-1">I forskrift 18. desember 2009 nr. 1839 om legemidler (legemiddelforskriften) gj&#xF8;res f&#xF8;lgende endringer:</article>
        <article class="defaultP" margin-top="true">Kapittel 16 skal lyde:</article>
        <article class="legalP" id="kapittel-1-ledd-2">Gebyr etter &#xA7; 15-3, &#xA7; 15-3A og &#xA7; 15-3B oppgitt i norske kroner: <table><caption data-caption-placement="before">S&#xF8;knad om markedsf&#xF8;ringstillatelse (Nasjonale)</caption><thead><tr><th data-text-align="left" data-vertical-align="top"/><th data-text-align="center" data-vertical-align="top"><i>Human</i></th><th data-text-align="center" data-vertical-align="top"><i>Veterin&#xE6;r</i></th></tr></thead><tbody><tr><td data-text-align="left" data-vertical-align="top">Fullstendig s&#xF8;knad, veletablert bruk (WEU), faste kombinasjoner<br/>Direktiv 2001/83/EF art. 8(3), 10a, 10b.<br/>Direktiv 2001/82/EF art. 12(3), 13a, 13b.</td><td data-text-align="center" data-vertical-align="top">442&#xA0;805</td><td data-text-align="center" data-vertical-align="top">442&#xA0;805</td></tr><tr><td data-text-align="left" data-vertical-align="top">Forenklet s&#xF8;knad, generisk, hybrid, biosimilar, &#xAB;informed consent&#xBB;<br/>Direktiv 2001/83/EF art. 10(1), 10(3), 10(4), 10c.<br/>Direktiv 2001/82/EF art. 13(1), 13(3), 13(4), 13c.</td><td data-text-align="center" data-vertical-align="top">166&#xA0;051</td><td data-text-align="center" data-vertical-align="top">166&#xA0;051</td></tr><tr><td data-text-align="left" data-vertical-align="top">Flere former og styrker s&#xF8;kt samtidig &#x2013; Til dyr: innen samme m&#xE5;lart(er)</td><td data-text-align="center" data-vertical-align="top">16&#xA0;606</td><td data-text-align="center" data-vertical-align="top">16&#xA0;606</td></tr><tr><td data-text-align="left" data-vertical-align="top">Flere former og styrker s&#xF8;kt samtidig (ulike m&#xE5;larter)</td><td data-text-align="center" data-vertical-align="top"/><td data-text-align="center" data-vertical-align="top">166&#xA0;051</td></tr><tr><td data-text-align="left" data-vertical-align="top">Annex I: s&#xF8;knader unntatt nye former og styrker, og for legemidler til dyr unntatt endring eller tillegg av ny n&#xE6;ringsmiddelproduserende m&#xE5;lart<sup class="footnotereference" data-footnotereferencevalue="1" data-unique-footnote-counter="1">1</sup></td><td data-text-align="center" data-vertical-align="top">99&#xA0;631</td><td data-text-align="center" data-vertical-align="top">83&#xA0;027</td></tr><tr><td data-text-align="left" data-vertical-align="top">Annex I (Line extension): Nye former/styrker &#x2013; Legemidler til dyr: innen samme m&#xE5;lart(er)<sup class="footnotereference" data-footnotereferencevalue="1" data-unique-footnote-counter="1">1</sup></td><td data-text-align="center" data-vertical-align="top">110&#xA0;702</td><td data-text-align="center" data-vertical-align="top">110&#xA0;702</td></tr><tr><td data-text-align="left" data-vertical-align="top">Annex I: Endring eller tillegg av ny n&#xE6;ringsmiddelproduserende m&#xE5;lart<sup class="footnotereference" data-footnotereferencevalue="1" data-unique-footnote-counter="1">1</sup></td><td data-text-align="center" data-vertical-align="top"/><td data-text-align="center" data-vertical-align="top">110&#xA0;702</td></tr><tr><td data-text-align="left" data-vertical-align="top">Duplikats&#xF8;knad (s&#xF8;kt samtidig)</td><td data-text-align="center" data-vertical-align="top">33&#xA0;210</td><td data-text-align="center" data-vertical-align="top">33&#xA0;210</td></tr><tr><td data-text-align="left" data-vertical-align="top">S&#xF8;knad om registrering av tradisjonelle plantebaserte legemidler, med HMPC-monografi</td><td data-text-align="center" data-vertical-align="top">166&#xA0;051</td><td data-text-align="center" data-vertical-align="top"/></tr><tr><td data-text-align="left" data-vertical-align="top">S&#xF8;knad om registrering av tradisjonelle plantebaserte legemidler uten HMPC-monografi</td><td data-text-align="center" data-vertical-align="top">221&#xA0;403</td><td data-text-align="center" data-vertical-align="top"/></tr><tr><td data-text-align="left" data-vertical-align="top">S&#xF8;knad om markedsf&#xF8;ringstillatelse for naturlegemidler</td><td data-text-align="center" data-vertical-align="top">221&#xA0;403</td><td data-text-align="center" data-vertical-align="top"/></tr><tr><td data-text-align="left" data-vertical-align="top">S&#xF8;knad som trekkes f&#xF8;r prosedyrestart &#x2013; administrasjonsgebyr</td><td data-text-align="center" data-vertical-align="top">22&#xA0;140</td><td data-text-align="center" data-vertical-align="top">22&#xA0;140</td></tr></tbody></table><table><caption data-caption-placement="before">Endringss&#xF8;knader og s&#xF8;knad om fornyelse (Nasjonale)</caption><thead><tr><th data-text-align="left" data-vertical-align="top"/><th data-text-align="center" data-vertical-align="top"><i>Human</i></th><th data-text-align="center" data-vertical-align="top"><i>Veterin&#xE6;r</i></th></tr></thead><tbody><tr><td data-text-align="left" data-vertical-align="top">Endring type IB som f&#xF8;rer til endring i preparatomtale, pakningsvedlegg og merking<sup class="footnotereference" data-footnotereferencevalue="2" data-unique-footnote-counter="2">2</sup><sup class="footnotereference" data-footnotereferencevalue="3" data-unique-footnote-counter="3">3</sup></td><td data-text-align="center" data-vertical-align="top">9&#xA0;410</td><td data-text-align="center" data-vertical-align="top">9&#xA0;410</td></tr><tr><td data-text-align="left" data-vertical-align="top">Endring type II; indikasjonsendring<sup class="footnotereference" data-footnotereferencevalue="2" data-unique-footnote-counter="2">2</sup><sup class="footnotereference" data-footnotereferencevalue="3" data-unique-footnote-counter="3">3</sup><sup class="footnotereference" data-footnotereferencevalue="4" data-unique-footnote-counter="4">4</sup> Legemidler til dyr: innen samme m&#xE5;lart(er)</td><td data-text-align="center" data-vertical-align="top">83&#xA0;027</td><td data-text-align="center" data-vertical-align="top">83&#xA0;027</td></tr><tr><td data-text-align="left" data-vertical-align="top">Endring type II; endring eller tillegg av ny ikke- n&#xE6;ringsmiddelproduserende m&#xE5;lart</td><td data-text-align="center" data-vertical-align="top"/><td data-text-align="center" data-vertical-align="top">83&#xA0;027</td></tr><tr><td data-text-align="left" data-vertical-align="top">Endret tilbakeholdelsestid</td><td data-text-align="center" data-vertical-align="top"/><td data-text-align="center" data-vertical-align="top">22&#xA0;140</td></tr><tr><td data-text-align="left" data-vertical-align="top">Endring type II; endring i reseptstatus<sup class="footnotereference" data-footnotereferencevalue="2" data-unique-footnote-counter="2">2</sup><sup class="footnotereference" data-footnotereferencevalue="3" data-unique-footnote-counter="3">3</sup></td><td data-text-align="center" data-vertical-align="top">83&#xA0;027</td><td data-text-align="center" data-vertical-align="top">83&#xA0;027</td></tr><tr><td data-text-align="left" data-vertical-align="top">&#xD8;vrige endringer type II<sup class="footnotereference" data-footnotereferencevalue="2" data-unique-footnote-counter="2">2</sup><sup class="footnotereference" data-footnotereferencevalue="3" data-unique-footnote-counter="3">3</sup><sup class="footnotereference" data-footnotereferencevalue="5" data-unique-footnote-counter="5">5</sup></td><td data-text-align="center" data-vertical-align="top">13&#xA0;838</td><td data-text-align="center" data-vertical-align="top">13&#xA0;838</td></tr><tr><td data-text-align="left" data-vertical-align="top">Fornyelser<sup class="footnotereference" data-footnotereferencevalue="6" data-unique-footnote-counter="6">6</sup></td><td data-text-align="center" data-vertical-align="top">44&#xA0;281</td><td data-text-align="center" data-vertical-align="top">44&#xA0;281</td></tr><tr><td data-text-align="left" data-vertical-align="top">Tradisjonelle plantebaserte legemidler; Endring type II; nytt bruksomr&#xE5;de<sup class="footnotereference" data-footnotereferencevalue="2" data-unique-footnote-counter="2">2</sup><sup class="footnotereference" data-footnotereferencevalue="3" data-unique-footnote-counter="3">3</sup><sup class="footnotereference" data-footnotereferencevalue="4" data-unique-footnote-counter="4">4</sup></td><td data-text-align="center" data-vertical-align="top">24&#xA0;907</td><td data-text-align="center" data-vertical-align="top"/></tr><tr><td data-text-align="left" data-vertical-align="top">Tradisjonelle plantebaserte legemidler; Endring type IB som f&#xF8;rer til endring i preparatomtale, pakningsvedlegg og merking<sup class="footnotereference" data-footnotereferencevalue="2" data-unique-footnote-counter="2">2</sup><sup class="footnotereference" data-footnotereferencevalue="3" data-unique-footnote-counter="3">3</sup></td><td data-text-align="center" data-vertical-align="top">9&#xA0;410</td><td data-text-align="center" data-vertical-align="top"/></tr><tr><td data-text-align="left" data-vertical-align="top">Tradisjonelle plantebaserte legemidler; &#xD8;vrige endringer type II<sup class="footnotereference" data-footnotereferencevalue="2" data-unique-footnote-counter="2">2</sup><sup class="footnotereference" data-footnotereferencevalue="3" data-unique-footnote-counter="3">3</sup></td><td data-text-align="center" data-vertical-align="top">13&#xA0;838</td><td data-text-align="center" data-vertical-align="top"/></tr><tr><td data-text-align="left" data-vertical-align="top">Tradisjonelle plantebaserte legemidler; Fornyelser<sup class="footnotereference" data-footnotereferencevalue="6" data-unique-footnote-counter="6">6</sup></td><td data-text-align="center" data-vertical-align="top">22&#xA0;140</td><td data-text-align="center" data-vertical-align="top"/></tr></tbody></table><table><caption data-caption-placement="before">Parallellimport (Nasjonale)</caption><thead><tr><th data-text-align="left" data-vertical-align="top"/><th data-text-align="center" data-vertical-align="top"><i>Human</i></th><th data-text-align="center" data-vertical-align="top"><i>Veterin&#xE6;r</i></th></tr></thead><tbody><tr><td data-text-align="left" data-vertical-align="top">S&#xF8;knad om markedsf&#xF8;ringstillatelse</td><td data-text-align="center" data-vertical-align="top">17&#xA0;712</td><td data-text-align="center" data-vertical-align="top">17&#xA0;712</td></tr><tr><td data-text-align="left" data-vertical-align="top">Fornyelser<sup class="footnotereference" data-footnotereferencevalue="6" data-unique-footnote-counter="6">6</sup></td><td data-text-align="center" data-vertical-align="top">5&#xA0;535</td><td data-text-align="center" data-vertical-align="top">5&#xA0;535</td></tr></tbody></table></article>
        <article class="defaultP">
          <i>MRP der Norge er RMS</i>
          <table>
            <caption data-caption-placement="before">S&#xF8;knad om markedsf&#xF8;ringstillatelse (MRP-RMS)</caption>
            <thead>
              <tr>
                <th data-text-align="left" data-vertical-align="top"/>
                <th data-text-align="center" data-vertical-align="top">
                  <i>Human</i>
                </th>
                <th data-text-align="center" data-vertical-align="top">
                  <i>Veterin&#xE6;r</i>
                </th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td data-text-align="left" data-vertical-align="top">Inng&#xE5;else av avtale om RMS-oppdrag<sup class="footnotereference" data-footnotereferencevalue="7" data-unique-footnote-counter="7">7</sup></td>
                <td data-text-align="center" data-vertical-align="top">55&#xA0;350</td>
                <td data-text-align="center" data-vertical-align="top">55&#xA0;350</td>
              </tr>
              <tr>
                <td data-text-align="left" data-vertical-align="top">Igangsetting av MRP-oppdrag, alle type MT- s&#xF8;knader<sup class="footnotereference" data-footnotereferencevalue="8" data-unique-footnote-counter="8">8</sup></td>
                <td data-text-align="center" data-vertical-align="top">110&#xA0;702</td>
                <td data-text-align="center" data-vertical-align="top">110&#xA0;702</td>
              </tr>
              <tr>
                <td data-text-align="left" data-vertical-align="top">Repeat use, alle type MT-s&#xF8;knader</td>
                <td data-text-align="center" data-vertical-align="top">110&#xA0;702</td>
                <td data-text-align="center" data-vertical-align="top">110&#xA0;702</td>
              </tr>
              <tr>
                <td data-text-align="left" data-vertical-align="top">Annex I: s&#xF8;knader unntatt nye former og styrker, og for legemidler til dyr unntatt endring eller tillegg av ny n&#xE6;ringsmiddelproduserende m&#xE5;lart<sup class="footnotereference" data-footnotereferencevalue="1" data-unique-footnote-counter="1">1</sup></td>
                <td data-text-align="center" data-vertical-align="top">99&#xA0;631</td>
                <td data-text-align="center" data-vertical-align="top">83&#xA0;027</td>
              </tr>
              <tr>
                <td data-text-align="left" data-vertical-align="top">Annex I (line extension): Nye former/styrker &#x2013; Legemidler til dyr: innen samme m&#xE5;lart(er)<sup class="footnotereference" data-footnotereferencevalue="1" data-unique-footnote-counter="1">1</sup></td>
                <td data-text-align="center" data-vertical-align="top">138&#xA0;376</td>
                <td data-text-align="center" data-vertical-align="top">138&#xA0;376</td>
              </tr>
              <tr>
                <td data-text-align="left" data-vertical-align="top">Annex I: Endring eller tillegg av ny n&#xE6;ringsmiddelproduserende m&#xE5;lart<sup class="footnotereference" data-footnotereferencevalue="1" data-unique-footnote-counter="1">1</sup></td>
                <td data-text-align="center" data-vertical-align="top"/>
                <td data-text-align="center" data-vertical-align="top">110&#xA0;702</td>
              </tr>
            </tbody>
          </table>
          <table>
            <caption data-caption-placement="before">Endringss&#xF8;knader og s&#xF8;knad om fornyelse (MRP-RMS)</caption>
            <thead>
              <tr>
                <th data-text-align="left" data-vertical-align="top"/>
                <th data-text-align="center" data-vertical-align="top">
                  <i>Human</i>
                </th>
                <th data-text-align="center" data-vertical-align="top">
                  <i>Veterin&#xE6;r</i>
                </th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td data-text-align="left" data-vertical-align="top">Endring type IB som f&#xF8;rer til endring i preparatomtale, pakningsvedlegg og merking<sup class="footnotereference" data-footnotereferencevalue="2" data-unique-footnote-counter="2">2</sup><sup class="footnotereference" data-footnotereferencevalue="3" data-unique-footnote-counter="3">3</sup></td>
                <td data-text-align="center" data-vertical-align="top">12&#xA0;176</td>
                <td data-text-align="center" data-vertical-align="top">12&#xA0;176</td>
              </tr>
              <tr>
                <td data-text-align="left" data-vertical-align="top">Endring type II; indikasjonsendring<sup class="footnotereference" data-footnotereferencevalue="2" data-unique-footnote-counter="2">2</sup><sup class="footnotereference" data-footnotereferencevalue="3" data-unique-footnote-counter="3">3</sup><sup class="footnotereference" data-footnotereferencevalue="4" data-unique-footnote-counter="4">4</sup> &#x2013; Legemidler til dyr: innen samme m&#xE5;lart(er)</td>
                <td data-text-align="center" data-vertical-align="top">83&#xA0;027</td>
                <td data-text-align="center" data-vertical-align="top">83&#xA0;027</td>
              </tr>
              <tr>
                <td data-text-align="left" data-vertical-align="top">Endring type II; endring eller tillegg av ny ikke- n&#xE6;ringsmiddelproduserende m&#xE5;lart</td>
                <td data-text-align="center" data-vertical-align="top"/>
                <td data-text-align="center" data-vertical-align="top">88&#xA0;561</td>
              </tr>
              <tr>
                <td data-text-align="left" data-vertical-align="top">Endret tilbakeholdelsestid</td>
                <td data-text-align="center" data-vertical-align="top"/>
                <td data-text-align="center" data-vertical-align="top">27&#xA0;675</td>
              </tr>
              <tr>
                <td data-text-align="left" data-vertical-align="top">&#xD8;vrige endringer type II<sup class="footnotereference" data-footnotereferencevalue="2" data-unique-footnote-counter="2">2</sup><sup class="footnotereference" data-footnotereferencevalue="3" data-unique-footnote-counter="3">3</sup><sup class="footnotereference" data-footnotereferencevalue="5" data-unique-footnote-counter="5">5</sup></td>
                <td data-text-align="center" data-vertical-align="top">13&#xA0;284</td>
                <td data-text-align="center" data-vertical-align="top">13&#xA0;284</td>
              </tr>
              <tr>
                <td data-text-align="left" data-vertical-align="top">Worksharing; indikasjonsendring<sup class="footnotereference" data-footnotereferencevalue="4" data-unique-footnote-counter="4">4</sup><sup class="footnotereference" data-footnotereferencevalue="9" data-unique-footnote-counter="9">9</sup></td>
                <td data-text-align="center" data-vertical-align="top">83&#xA0;027</td>
                <td data-text-align="center" data-vertical-align="top">83&#xA0;027</td>
              </tr>
              <tr>
                <td data-text-align="left" data-vertical-align="top">Worksharing; Type IB som f&#xF8;rer til endring i preparatomtale, pakningsvedlegg og merking<sup class="footnotereference" data-footnotereferencevalue="2" data-unique-footnote-counter="2">2</sup><sup class="footnotereference" data-footnotereferencevalue="3" data-unique-footnote-counter="3">3</sup><sup class="footnotereference" data-footnotereferencevalue="9" data-unique-footnote-counter="9">9</sup></td>
                <td data-text-align="center" data-vertical-align="top">11&#xA0;071</td>
                <td data-text-align="center" data-vertical-align="top">11&#xA0;071</td>
              </tr>
              <tr>
                <td data-text-align="left" data-vertical-align="top">Worksharing; harmonisering av SmPC</td>
                <td data-text-align="center" data-vertical-align="top">27&#xA0;675</td>
                <td data-text-align="center" data-vertical-align="top">27&#xA0;675</td>
              </tr>
              <tr>
                <td data-text-align="left" data-vertical-align="top">Worksharing; &#xF8;vrige endringer type II<sup class="footnotereference" data-footnotereferencevalue="9" data-unique-footnote-counter="9">9</sup></td>
                <td data-text-align="center" data-vertical-align="top">13&#xA0;838</td>
                <td data-text-align="center" data-vertical-align="top">13&#xA0;838</td>
              </tr>
              <tr>
                <td data-text-align="left" data-vertical-align="top">Fornyelser<sup class="footnotereference" data-footnotereferencevalue="6" data-unique-footnote-counter="6">6</sup></td>
                <td data-text-align="center" data-vertical-align="top">44&#xA0;281</td>
                <td data-text-align="center" data-vertical-align="top">44&#xA0;281</td>
              </tr>
              <tr>
                <td data-text-align="left" data-vertical-align="top">Tradisjonelle plantebaserte legemidler; Endring type IB som f&#xF8;rer til endring i preparatomtale, pakningsvedlegg og merking<sup class="footnotereference" data-footnotereferencevalue="2" data-unique-footnote-counter="2">2</sup><sup class="footnotereference" data-footnotereferencevalue="3" data-unique-footnote-counter="3">3</sup></td>
                <td data-text-align="center" data-vertical-align="top">8&#xA0;856</td>
                <td data-text-align="center" data-vertical-align="top"/>
              </tr>
              <tr>
                <td data-text-align="left" data-vertical-align="top">Tradisjonelle plantebaserte legemidler; Endringer, type II<sup class="footnotereference" data-footnotereferencevalue="2" data-unique-footnote-counter="2">2</sup><sup class="footnotereference" data-footnotereferencevalue="3" data-unique-footnote-counter="3">3</sup></td>
                <td data-text-align="center" data-vertical-align="top">13&#xA0;284</td>
                <td data-text-align="center" data-vertical-align="top"/>
              </tr>
              <tr>
                <td data-text-align="left" data-vertical-align="top">Tradisjonelle plantebaserte legemidler; Fornyelser<sup class="footnotereference" data-footnotereferencevalue="6" data-unique-footnote-counter="6">6</sup></td>
                <td data-text-align="center" data-vertical-align="top">22&#xA0;140</td>
                <td data-text-align="center" data-vertical-align="top"/>
              </tr>
            </tbody>
          </table>
        </article>
        <article class="defaultP">
          <i>MRP der Norge er CMS</i>
          <table>
            <caption data-caption-placement="before">S&#xF8;knad om markedsf&#xF8;ringstillatelse (MRP-CMS)</caption>
            <thead>
              <tr>
                <th data-text-align="left" data-vertical-align="top"/>
                <th data-text-align="center" data-vertical-align="top">
                  <i>Human</i>
                </th>
                <th data-text-align="center" data-vertical-align="top">
                  <i>Veterin&#xE6;r</i>
                </th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td data-text-align="left" data-vertical-align="top">Fullstendige s&#xF8;knader, bibliografiske, faste kombinasjoner<br/>Direktiv 2001/83/EF art. 8(3), 10a, 10b.<br/>Direktiv 2001/82/EF art. 12(3), 13a, 13b.</td>
                <td data-text-align="center" data-vertical-align="top">110&#xA0;702</td>
                <td data-text-align="center" data-vertical-align="top">110&#xA0;702</td>
              </tr>
              <tr>
                <td data-text-align="left" data-vertical-align="top">Forenklet s&#xF8;knad, generisk, hybrid, biosimilar, &#xAB;informed consent&#xBB;<br/>Direktiv 2001/83/EF art. 10(1), 10(3), 10(4), 10c.<br/>Direktiv 2001/82/EF art. 13(1), 13(3), 13(4), 13c.</td>
                <td data-text-align="center" data-vertical-align="top">83&#xA0;027</td>
                <td data-text-align="center" data-vertical-align="top">83&#xA0;027</td>
              </tr>
              <tr>
                <td data-text-align="left" data-vertical-align="top">Flere former og styrker s&#xF8;kt samtidig &#x2013; Til dyr: innen samme m&#xE5;lart(er)</td>
                <td data-text-align="center" data-vertical-align="top">16&#xA0;606</td>
                <td data-text-align="center" data-vertical-align="top">16&#xA0;606</td>
              </tr>
              <tr>
                <td data-text-align="left" data-vertical-align="top">Flere former og styrker s&#xF8;kt samtidig (ulike m&#xE5;larter)</td>
                <td data-text-align="center" data-vertical-align="top"/>
                <td data-text-align="center" data-vertical-align="top">94&#xA0;095</td>
              </tr>
              <tr>
                <td data-text-align="left" data-vertical-align="top">Annex I: s&#xF8;knader unntatt nye former og styrker, og for legemidler til dyr unntatt endring eller tillegg av ny n&#xE6;ringsmiddelproduserende m&#xE5;lart<sup class="footnotereference" data-footnotereferencevalue="1" data-unique-footnote-counter="1">1</sup></td>
                <td data-text-align="center" data-vertical-align="top">55&#xA0;350</td>
                <td data-text-align="center" data-vertical-align="top">55&#xA0;350</td>
              </tr>
              <tr>
                <td data-text-align="left" data-vertical-align="top">Annex I: Nye former/styrker (line extension) &#x2013; Legemidler til dyr: innen samme m&#xE5;lart(er)<sup class="footnotereference" data-footnotereferencevalue="1" data-unique-footnote-counter="1">1</sup></td>
                <td data-text-align="center" data-vertical-align="top">55&#xA0;350</td>
                <td data-text-align="center" data-vertical-align="top">55&#xA0;350</td>
              </tr>
              <tr>
                <td data-text-align="left" data-vertical-align="top">Annex I: Endring eller tillegg av ny n&#xE6;ringsmiddelproduserende m&#xE5;lart<sup class="footnotereference" data-footnotereferencevalue="1" data-unique-footnote-counter="1">1</sup></td>
                <td data-text-align="center" data-vertical-align="top"/>
                <td data-text-align="center" data-vertical-align="top">33&#xA0;210</td>
              </tr>
              <tr>
                <td data-text-align="left" data-vertical-align="top">S&#xF8;knad om registrering av tradisjonelle plantebaserte legemidler med HMPC-monografi</td>
                <td data-text-align="center" data-vertical-align="top">83&#xA0;027</td>
                <td data-text-align="center" data-vertical-align="top"/>
              </tr>
              <tr>
                <td data-text-align="left" data-vertical-align="top">S&#xF8;knad om registrering av tradisjonelle plantebaserte legemidler uten HMPC-monografi (etter avtale)</td>
                <td data-text-align="center" data-vertical-align="top">110&#xA0;702</td>
                <td data-text-align="center" data-vertical-align="top"/>
              </tr>
              <tr>
                <td data-text-align="left" data-vertical-align="top">S&#xF8;knad som trekkes f&#xF8;r prosedyrestart &#x2013; administrasjonsgebyr</td>
                <td data-text-align="center" data-vertical-align="top">22&#xA0;140</td>
                <td data-text-align="center" data-vertical-align="top">22&#xA0;140</td>
              </tr>
            </tbody>
          </table>
          <table>
            <caption data-caption-placement="before">Endringss&#xF8;knader og s&#xF8;knad om fornyelser (MRP-CMS)</caption>
            <thead>
              <tr>
                <th data-text-align="left" data-vertical-align="top"/>
                <th data-text-align="center" data-vertical-align="top">
                  <i>Human</i>
                </th>
                <th data-text-align="center" data-vertical-align="top">
                  <i>Veterin&#xE6;r</i>
                </th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td data-text-align="left" data-vertical-align="top">Endring type IB som f&#xF8;rer til endring i preparatomtale, pakningsvedlegg og merking<sup class="footnotereference" data-footnotereferencevalue="2" data-unique-footnote-counter="2">2</sup><sup class="footnotereference" data-footnotereferencevalue="3" data-unique-footnote-counter="3">3</sup></td>
                <td data-text-align="center" data-vertical-align="top">7&#xA0;196</td>
                <td data-text-align="center" data-vertical-align="top">7&#xA0;196</td>
              </tr>
              <tr>
                <td data-text-align="left" data-vertical-align="top">Endring type II; indikasjonsendring<sup class="footnotereference" data-footnotereferencevalue="2" data-unique-footnote-counter="2">2</sup><sup class="footnotereference" data-footnotereferencevalue="3" data-unique-footnote-counter="3">3</sup><sup class="footnotereference" data-footnotereferencevalue="4" data-unique-footnote-counter="4">4</sup> &#x2013; Legemidler til dyr: innen samme m&#xE5;lart(er)</td>
                <td data-text-align="center" data-vertical-align="top">38&#xA0;746</td>
                <td data-text-align="center" data-vertical-align="top">38&#xA0;746</td>
              </tr>
              <tr>
                <td data-text-align="left" data-vertical-align="top">Endring type II; endring eller tillegg av ny ikke- n&#xE6;ringsmiddelproduserende m&#xE5;lart</td>
                <td data-text-align="center" data-vertical-align="top">&#x2013;</td>
                <td data-text-align="center" data-vertical-align="top">27&#xA0;675</td>
              </tr>
              <tr>
                <td data-text-align="left" data-vertical-align="top">Endret tilbakeholdelsestid</td>
                <td data-text-align="center" data-vertical-align="top">&#x2013;</td>
                <td data-text-align="center" data-vertical-align="top">7&#xA0;971</td>
              </tr>
              <tr>
                <td data-text-align="left" data-vertical-align="top">&#xD8;vrige endringer type II<sup class="footnotereference" data-footnotereferencevalue="2" data-unique-footnote-counter="2">2</sup><sup class="footnotereference" data-footnotereferencevalue="3" data-unique-footnote-counter="3">3</sup><sup class="footnotereference" data-footnotereferencevalue="5" data-unique-footnote-counter="5">5</sup></td>
                <td data-text-align="center" data-vertical-align="top">11&#xA0;071</td>
                <td data-text-align="center" data-vertical-align="top">11&#xA0;071</td>
              </tr>
              <tr>
                <td data-text-align="left" data-vertical-align="top">Worksharing; indikasjonsendring<sup class="footnotereference" data-footnotereferencevalue="9" data-unique-footnote-counter="9">9</sup></td>
                <td data-text-align="center" data-vertical-align="top">33&#xA0;210</td>
                <td data-text-align="center" data-vertical-align="top">33&#xA0;210</td>
              </tr>
              <tr>
                <td data-text-align="left" data-vertical-align="top">Worksharing Type IB som f&#xF8;rer til endring i preparatomtale, pakningsvedlegg og merking<sup class="footnotereference" data-footnotereferencevalue="2" data-unique-footnote-counter="2">2</sup><sup class="footnotereference" data-footnotereferencevalue="3" data-unique-footnote-counter="3">3</sup><sup class="footnotereference" data-footnotereferencevalue="9" data-unique-footnote-counter="9">9</sup></td>
                <td data-text-align="center" data-vertical-align="top">11&#xA0;071</td>
                <td data-text-align="center" data-vertical-align="top">11&#xA0;071</td>
              </tr>
              <tr>
                <td data-text-align="left" data-vertical-align="top">Worksharing harmonisering av SmPC</td>
                <td data-text-align="center" data-vertical-align="top">22&#xA0;140</td>
                <td data-text-align="center" data-vertical-align="top">22&#xA0;140</td>
              </tr>
              <tr>
                <td data-text-align="left" data-vertical-align="top">Worksharing &#xF8;vrige endringer type II<sup class="footnotereference" data-footnotereferencevalue="9" data-unique-footnote-counter="9">9</sup></td>
                <td data-text-align="center" data-vertical-align="top">11&#xA0;071</td>
                <td data-text-align="center" data-vertical-align="top">11&#xA0;071</td>
              </tr>
              <tr>
                <td data-text-align="left" data-vertical-align="top">Fornyelser<sup class="footnotereference" data-footnotereferencevalue="6" data-unique-footnote-counter="6">6</sup></td>
                <td data-text-align="center" data-vertical-align="top">18&#xA0;819</td>
                <td data-text-align="center" data-vertical-align="top">18&#xA0;819</td>
              </tr>
              <tr>
                <td data-text-align="left" data-vertical-align="top">Tradisjonelle plantebaserte legemidler; Endring type IB som f&#xF8;rer til endring i preparatomtale, pakningsvedlegg og merking<sup class="footnotereference" data-footnotereferencevalue="2" data-unique-footnote-counter="2">2</sup><sup class="footnotereference" data-footnotereferencevalue="3" data-unique-footnote-counter="3">3</sup></td>
                <td data-text-align="center" data-vertical-align="top">5&#xA0;535</td>
                <td data-text-align="center" data-vertical-align="top"/>
              </tr>
              <tr>
                <td data-text-align="left" data-vertical-align="top">Tradisjonelle plantebaserte legemidler; Endringer, type II<sup class="footnotereference" data-footnotereferencevalue="2" data-unique-footnote-counter="2">2</sup><sup class="footnotereference" data-footnotereferencevalue="3" data-unique-footnote-counter="3">3</sup></td>
                <td data-text-align="center" data-vertical-align="top">7&#xA0;748</td>
                <td data-text-align="center" data-vertical-align="top"/>
              </tr>
              <tr>
                <td data-text-align="left" data-vertical-align="top">Tradisjonelle plantebaserte legemidler; Fornyelser<sup class="footnotereference" data-footnotereferencevalue="6" data-unique-footnote-counter="6">6</sup></td>
                <td data-text-align="center" data-vertical-align="top">5&#xA0;535</td>
                <td data-text-align="center" data-vertical-align="top"/>
              </tr>
            </tbody>
          </table>
        </article>
        <article class="defaultP">
          <i>DCP der Norge er RMS</i>
          <table>
            <caption data-caption-placement="before">S&#xF8;knad om markedsf&#xF8;ringstillatelse (DCP-RMS)</caption>
            <thead>
              <tr>
                <th data-text-align="left" data-vertical-align="top"/>
                <th data-text-align="center" data-vertical-align="top">
                  <i>Human</i>
                </th>
                <th data-text-align="center" data-vertical-align="top">
                  <i>Veterin&#xE6;r</i>
                </th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td data-text-align="left" data-vertical-align="top">Inng&#xE5;else av avtale om RMS-oppdrag<sup class="footnotereference" data-footnotereferencevalue="7" data-unique-footnote-counter="7">7</sup></td>
                <td data-text-align="center" data-vertical-align="top">55&#xA0;350</td>
                <td data-text-align="center" data-vertical-align="top">55&#xA0;350</td>
              </tr>
              <tr>
                <td data-text-align="left" data-vertical-align="top">Fullstendige s&#xF8;knader, bibliografiske, faste kombinasjoner<br/>Direktiv 2001/83/EF art. 8(3), 10a, 10b.<br/>Direktiv 2001/82/EF art. 12(3), 13a, 13b.</td>
                <td data-text-align="center" data-vertical-align="top">387&#xA0;455</td>
                <td data-text-align="center" data-vertical-align="top">387&#xA0;455</td>
              </tr>
              <tr>
                <td data-text-align="left" data-vertical-align="top">Forenklet s&#xF8;knad, generisk, hybrid, biosimilar, &#xAB;Informed consent&#xBB;<br/>Direktiv 2001/83/EF art. 10(1), 10(3), 10(4), 10c.<br/>Direktiv 2001/82/EF art. 13(1), 13(3), 13(4), 13c.</td>
                <td data-text-align="center" data-vertical-align="top">166&#xA0;051</td>
                <td data-text-align="center" data-vertical-align="top">166&#xA0;051</td>
              </tr>
              <tr>
                <td data-text-align="left" data-vertical-align="top">Flere former og styrker s&#xF8;kt samtidig. Til dyr: innen samme m&#xE5;lart(er)</td>
                <td data-text-align="center" data-vertical-align="top">16&#xA0;606</td>
                <td data-text-align="center" data-vertical-align="top">16&#xA0;606</td>
              </tr>
              <tr>
                <td data-text-align="left" data-vertical-align="top">Flere former og styrker s&#xF8;kt samtidig (ulike m&#xE5;larter)</td>
                <td data-text-align="center" data-vertical-align="top"/>
                <td data-text-align="center" data-vertical-align="top">83&#xA0;027</td>
              </tr>
              <tr>
                <td data-text-align="left" data-vertical-align="top">Annex I: s&#xF8;knader unntatt nye former og styrker, og for legemidler til dyr unntatt endring eller tillegg av ny n&#xE6;ringsmiddelproduserende m&#xE5;lart<sup class="footnotereference" data-footnotereferencevalue="1" data-unique-footnote-counter="1">1</sup></td>
                <td data-text-align="center" data-vertical-align="top">121&#xA0;771</td>
                <td data-text-align="center" data-vertical-align="top">121&#xA0;771</td>
              </tr>
              <tr>
                <td data-text-align="left" data-vertical-align="top">Annex I: Nye former/styrker (lineextension) Legemidler til dyr: innen samme m&#xE5;lart(er)<sup class="footnotereference" data-footnotereferencevalue="1" data-unique-footnote-counter="1">1</sup></td>
                <td data-text-align="center" data-vertical-align="top">138&#xA0;376</td>
                <td data-text-align="center" data-vertical-align="top">138&#xA0;376</td>
              </tr>
              <tr>
                <td data-text-align="left" data-vertical-align="top">Annex I: Endring eller tillegg av ny n&#xE6;ringsmiddelproduserende m&#xE5;lart<sup class="footnotereference" data-footnotereferencevalue="1" data-unique-footnote-counter="1">1</sup></td>
                <td data-text-align="center" data-vertical-align="top"/>
                <td data-text-align="center" data-vertical-align="top">94&#xA0;095</td>
              </tr>
              <tr>
                <td data-text-align="left" data-vertical-align="top">S&#xF8;knad om registrering av tradisjonelle plantebaserte legemidler, med HMPC-monografi</td>
                <td data-text-align="center" data-vertical-align="top">166&#xA0;051</td>
                <td data-text-align="center" data-vertical-align="top"/>
              </tr>
              <tr>
                <td data-text-align="left" data-vertical-align="top">S&#xF8;knad om registrering av tradisjonelle plantebaserte legemidler, uten HMPC-monografi (etter avtale)</td>
                <td data-text-align="center" data-vertical-align="top">276&#xA0;753</td>
                <td data-text-align="center" data-vertical-align="top"/>
              </tr>
            </tbody>
          </table>
        </article>
        <article class="defaultP">
          <i>DCP der Norge er CMS</i>
          <table>
            <caption data-caption-placement="before">S&#xF8;knad om markedsf&#xF8;ringstillatelse (DCP-CMS)</caption>
            <thead>
              <tr>
                <th data-text-align="left" data-vertical-align="top"/>
                <th data-text-align="center" data-vertical-align="top">
                  <i>Human</i>
                </th>
                <th data-text-align="center" data-vertical-align="top">
                  <i>Veterin&#xE6;r</i>
                </th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td data-text-align="left" data-vertical-align="top">Fullstendige s&#xF8;knader, bibliografiske, faste kombinasjoner<br/>Direktiv 2001/83/EF art. 8(3), 10a, 10b.<br/>Direktiv 2001/82/EF art. 12(3), 13a, 13b.</td>
                <td data-text-align="center" data-vertical-align="top">110&#xA0;702</td>
                <td data-text-align="center" data-vertical-align="top">110&#xA0;702</td>
              </tr>
              <tr>
                <td data-text-align="left" data-vertical-align="top">Forenklet s&#xF8;knad, generisk, hybrid, hiosimilar, &#xAB;informed consent&#xBB;<br/>Direktiv 2001/83/EF art. 10(1), 10(3),10(4),10c.<br/>Direktiv 2001/82/EF art. 13(1), 13(3), 13(4), 13c.</td>
                <td data-text-align="center" data-vertical-align="top">83&#xA0;027</td>
                <td data-text-align="center" data-vertical-align="top">83&#xA0;027</td>
              </tr>
              <tr>
                <td data-text-align="left" data-vertical-align="top">Flere former og styrker s&#xF8;kt samtidig. Til dyr: innen samme m&#xE5;lart(er)</td>
                <td data-text-align="center" data-vertical-align="top">16&#xA0;606</td>
                <td data-text-align="center" data-vertical-align="top">16&#xA0;606</td>
              </tr>
              <tr>
                <td data-text-align="left" data-vertical-align="top">Flere former og styrker s&#xF8;kt samtidig (ulike m&#xE5;larter)</td>
                <td data-text-align="center" data-vertical-align="top"/>
                <td data-text-align="center" data-vertical-align="top">83&#xA0;027</td>
              </tr>
              <tr>
                <td data-text-align="left" data-vertical-align="top">Duplikats&#xF8;knad (s&#xF8;kt samtidig)</td>
                <td data-text-align="center" data-vertical-align="top">33&#xA0;210</td>
                <td data-text-align="center" data-vertical-align="top">33&#xA0;210</td>
              </tr>
              <tr>
                <td data-text-align="left" data-vertical-align="top">Annex I: s&#xF8;knader unntatt nye former og styrker, og for legemidler til dyr unntatt endring eller tillegg av ny n&#xE6;ringsmiddelproduserende m&#xE5;lart<sup class="footnotereference" data-footnotereferencevalue="1" data-unique-footnote-counter="1">1</sup></td>
                <td data-text-align="center" data-vertical-align="top">55&#xA0;350</td>
                <td data-text-align="center" data-vertical-align="top">55&#xA0;350</td>
              </tr>
              <tr>
                <td data-text-align="left" data-vertical-align="top">Annex I: Nye former/styrker (lineextension) Legemidler til dyr: innen samme m&#xE5;lart(er)<sup class="footnotereference" data-footnotereferencevalue="1" data-unique-footnote-counter="1">1</sup></td>
                <td data-text-align="center" data-vertical-align="top">55&#xA0;350</td>
                <td data-text-align="center" data-vertical-align="top">55&#xA0;350</td>
              </tr>
              <tr>
                <td data-text-align="left" data-vertical-align="top">Annex I: Endring eller tillegg av ny n&#xE6;ringsmiddelproduserendem&#xE5;lart1</td>
                <td data-text-align="center" data-vertical-align="top"/>
                <td data-text-align="center" data-vertical-align="top">49&#xA0;816</td>
              </tr>
              <tr>
                <td data-text-align="left" data-vertical-align="top">S&#xF8;knad om registrering av tradisjonelle plantebaserte legemidler, med HMPC-monografi</td>
                <td data-text-align="center" data-vertical-align="top">83&#xA0;027</td>
                <td data-text-align="center" data-vertical-align="top"/>
              </tr>
              <tr>
                <td data-text-align="left" data-vertical-align="top">S&#xF8;knad om registrering av tradisjonelle plantebaserte legemidler uten HMPC-monografi (etter avtale)</td>
                <td data-text-align="center" data-vertical-align="top">110&#xA0;702</td>
                <td data-text-align="center" data-vertical-align="top"/>
              </tr>
              <tr>
                <td data-text-align="left" data-vertical-align="top">S&#xF8;knad som trekkes f&#xF8;r prosedyrestart &#x2013; Administrasjonsgebyr</td>
                <td data-text-align="center" data-vertical-align="top">22&#xA0;140</td>
                <td data-text-align="center" data-vertical-align="top">22&#xA0;140</td>
              </tr>
            </tbody>
          </table>
          <table>
            <caption data-caption-placement="before">Hom&#xF8;opatiske legemidler</caption>
            <thead>
              <tr>
                <th data-text-align="left" data-vertical-align="top"/>
                <th data-text-align="center" data-vertical-align="top">
                  <i>Human</i>
                </th>
                <th data-text-align="center" data-vertical-align="top">
                  <i>Veterin&#xE6;r</i>
                </th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td data-text-align="left" data-vertical-align="top">S&#xF8;knad om registrering, gebyret dekker alle fortynningsgrader av en legemiddelform</td>
                <td data-text-align="center" data-vertical-align="top">1&#xA0;107</td>
                <td data-text-align="center" data-vertical-align="top">1&#xA0;107</td>
              </tr>
              <tr>
                <td data-text-align="left" data-vertical-align="top">Endring type II</td>
                <td data-text-align="center" data-vertical-align="top">1&#xA0;107</td>
                <td data-text-align="center" data-vertical-align="top">1&#xA0;107</td>
              </tr>
              <tr>
                <td data-text-align="left" data-vertical-align="top">Fornyelse</td>
                <td data-text-align="center" data-vertical-align="top">1&#xA0;107</td>
                <td data-text-align="center" data-vertical-align="top">1&#xA0;107</td>
              </tr>
            </tbody>
          </table>
          <table>
            <caption data-caption-placement="before">Kliniske studier</caption>
            <thead>
              <tr>
                <th data-text-align="left" data-vertical-align="top"/>
                <th data-text-align="center" data-vertical-align="top">
                  <i>Human</i>
                </th>
                <th data-text-align="center" data-vertical-align="top">
                  <i>Veterin&#xE6;r</i>
                </th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td data-text-align="left" data-vertical-align="top">Kliniske utpr&#xF8;vinger &#x2013; Ny studie</td>
                <td data-text-align="center" data-vertical-align="top">10&#xA0;810</td>
                <td data-text-align="center" data-vertical-align="top">10&#xA0;810</td>
              </tr>
              <tr>
                <td data-text-align="left" data-vertical-align="top">Kliniske utpr&#xF8;vinger &#x2013; Endringer (Substensial amendments)</td>
                <td data-text-align="center" data-vertical-align="top">5&#xA0;405</td>
                <td data-text-align="center" data-vertical-align="top">5&#xA0;405</td>
              </tr>
            </tbody>
          </table>
          <table>
            <caption data-caption-placement="before">S&#xF8;knader &#x2013; WHO-sertifikat</caption>
            <thead>
              <tr>
                <th data-text-align="left" data-vertical-align="top"/>
                <th data-text-align="center" data-vertical-align="top">&#xA0;</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td data-text-align="left" data-vertical-align="top">WHO-sertifikat</td>
                <td data-text-align="center" data-vertical-align="top">5&#xA0;405</td>
              </tr>
            </tbody>
          </table>
        </article>
        <article class="defaultP">Noter</article>
        <footer class="footnotes">
          <article class="footnote" data-name="1" data-unique-footnote-counter="1"><span class="footnoteLabel">1</span> Annex I til forordning (EF) nr. 1234/2008.</article>
          <article class="footnote" data-name="2" data-unique-footnote-counter="2"><span class="footnoteLabel">2</span> Dersom &#xE9;n endring gjelder flere former og styrker av samme preparat betales ett gebyr.</article>
          <article class="footnote" data-name="3" data-unique-footnote-counter="3"><span class="footnoteLabel">3</span> En endring som f&#xF8;rer til flere endringer anses i gebyrsammenheng som &#xE9;n endring.</article>
          <article class="footnote" data-name="4" data-unique-footnote-counter="4"><span class="footnoteLabel">4</span> Gjelder ikke spr&#xE5;klige endringer, flytting av tekst eller informasjon om manglende data til barn. Disse er &#xF8;vrige type II-endringer.</article>
          <article class="footnote" data-name="5" data-unique-footnote-counter="5"><span class="footnoteLabel">5</span> Gjelder ogs&#xE5; doseringsendringer.</article>
          <article class="footnote" data-name="6" data-unique-footnote-counter="6"><span class="footnoteLabel">6</span> Gjelder for hver MT.</article>
          <article class="footnote" data-name="7" data-unique-footnote-counter="7"><span class="footnoteLabel">7</span> Gjelder per oppdrag. Refunderes ikke.</article>
          <article class="footnote" data-name="8" data-unique-footnote-counter="8"><span class="footnoteLabel">8</span> Gjelder uansett s&#xF8;kergrunnlag.</article>
          <article class="footnote" data-name="9" data-unique-footnote-counter="9"><span class="footnoteLabel">9</span> Ett gebyr per gebyrpliktig endring (uavhengig av antall preparater som inng&#xE5;r i worksharing-prosedyren).</article>
        </footer>
        <article class="defaultP">
          <i>Merk:</i>
          <ul class="defaultList">
            <li data-li-identifier="-" data-name="-">
              <article class="listArticle" id="kapittel-1-ledd-2-punkt-1">
                <article class="legalP" id="kapittel-1-ledd-2-punkt-1-ledd-1">For grupperte endringer i henhold til forordning (EF) nr. 1234/2008 vil det bli tatt gebyr for hver endring som er gebyrpliktig.</article>
              </article>
            </li>
            <li data-li-identifier="-" data-name="-">
              <article class="listArticle" id="kapittel-1-ledd-2-punkt-2">
                <article class="legalP" id="kapittel-1-ledd-2-punkt-2-ledd-1">Det skal ogs&#xE5; betales gebyr for endringer og fornyelser for preparater som har markedsf&#xF8;ringstillatelse uten norsk produktinformasjon.</article>
              </article>
            </li>
            <li data-li-identifier="-" data-name="-">
              <article class="listArticle" id="kapittel-1-ledd-2-punkt-3">
                <article class="legalP" id="kapittel-1-ledd-2-punkt-3-ledd-1">Det tas ikke gebyr for type IA endringer og endringer type IB uten endringer i preparatomtale, pakningsvedlegg og merking.</article>
              </article>
            </li>
            <li data-li-identifier="-" data-name="-">
              <article class="listArticle" id="kapittel-1-ledd-2-punkt-4">
                <article class="legalP" id="kapittel-1-ledd-2-punkt-4-ledd-1">For legemidler til MUMS (Minor Use/Minor Species) er det 50&#xA0;% reduksjon i gebyr. MUMS- status m&#xE5; avklares p&#xE5; forh&#xE5;nd med Legemiddelverket.</article>
              </article>
            </li>
          </ul>
        </article>
      </section>
      <section class="section" data-name="kapII" id="kapittel-2" data-lovdata-URL="LTI/forskrift/2021-12-12-3513/KAPITTEL_2">
        <h2 data-text-align="center">II</h2>
        <article class="legalP" id="kapittel-2-ledd-1">Forskriften trer i kraft 1. januar 2022.</article>
      </section>
    </main>
  </body>
</html>
